Prioritizing Fertility Care in Sickle Cell Disease Treatment
Researchers proposed that integrating standardized fertility care into SCD treatment is a requisite of high-quality, personalized care
Home
Rondaptivon Pegol Shows Favorability Tolerability and Safety in Hemophilia A
Researchers sought to determine whether rondaptivon pegol would be an effective treatment to increase endogenous FVIII levels in patients with hemophilia A.
Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Antimicrobial Stewardship Team Improved Use of Carbapenem in Hematology Patients
A study sought to determine the effect of an antimicrobial stewardship team on carbapenem therapy in patients with hematologic disorders.
Use of Vena Cava Filters in VTE Patients Is Safe, Effective
Few adverse events seen, even in prophylactic use.
Genetic Variants Impact Residual Disease and Outcomes in Acute Myeloid Leukemia Allo-HSCT
Researchers sought to determine whether certain genetic variants would impact outcomes for patients with AML in first remission prior to undergoing allo-HSCT.
Magrolimab Plus Azacitidine Well Tolerated With Promising Efficacy in Higher-Risk Myelodysplastic Syndrome
Researchers sought to determine whether magrolimab combined with azacitidine would be an effective treatment for patients with high-risk MDS.
Update on Therapeutic Options for Myelofibrosis
A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.
Treatment Selection and Symptom Management After MDS/MDN Diagnosis
A review of MDS/MDN, including new WHO guidelines and collaborative strategies for managing the care of patients with lower-risk MDS.
Dabrafenib and Trametinib Show Promise in Relapsed/Refractory Hairy Cell Leukemia
Researchers sought to determine whether combination dabrafenib and trametinib would be effective in patients with relapsed/refractory HCL.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Leukemia
Loading... 
Loading...